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Summary 
Adrenal chromaffin cells (CCs) express high-voltage activated calcium channels (VACCs) of 
the L, N and PQ subtypes; additionally, T-type low-VACCs are also expressed during embryo 
and neonatal life. Effects of the more frequently used T channel blockers NNC 55-0396 (NNC), 
mibefradil, and Ni
2+
 on the whole-cell Ba
2+
 current (IBa), the K
+
-elicited [Ca
2+
]c transients and 
catecholamine secretion, have been studied in adult bovine CCs (BCCs) and rat embryo CCs 
(RECCs). NNC, mibefradil, and Ni
2+
 blocked BCC IBa with IC50 of 1.8, 4.9 and 70 µM, while 
IC50 to block IBa in RECCs were 2.1, 4.4 and 41 µM. Pronounced blockade of K
+
-elicited [Ca
2+
]c 
transients and secretion was also elicited by the three agents. However, the hypoxia-induced 
secretion (HIS) of catecholamine in RECCs was blocked substantially (75%) with thresholds 
concentrations of NCC (IC20 to block IBa); this was not the case for mibefradil and Ni
2+
 that 
required higher concentrations to block the HIS response. Thus, out of the three compounds, 
NNC seemed to be an adequate pharmacological tool to discern the contribution of T channels 
to the HIS response, without a contamination with high-VACCs blockade. 
 
Keywords: bovine chromaffin cells, hypoxia, calcium, NNC 55-0396, rat embryo chromaffin 
cells, voltage activated calcium channels. 
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1. INTRODUCTION 
Up to ten members of the voltage-activated calcium channel family (VACCs) serving distinct 
roles in cell signaling, have been identified in mammals (Catterall, 1998). High-VACCs are 
targeted by several selective toxins and organics compounds; thus, N-type channels (1B, 
Cav2.2) is blocked by -conotoxin MVIIA, PQ-type (1A, Cav2.1) is blocked by -conotoxins 
MVIIC and MVIID, L-type (1S/Cav1.1, 1C/Cav1.2, 1D/Cav1.3, 1F/Cav1.4) is targeted by 
1,4-dihydropyridines derivatives blockers (nifedipine) and activators (Bayk8644), and R-type 
(1E/Cav2.3) is blocked by SNX-482 (de Diego et al., 2014). In contrast, the blockers of T-type 
low-VACCs (1G/Cav3.1, 1H/Cav3.2, 1I/Cav3.3) so far available have poorer selectivity. For 
instance nickel (Ni
2+
) is more selective than cadmium (Cd
2+
) (Carbone & Lux, 1984). However, 
this selectivity is true for 1H channels but not for 1G and 1I that are blocked by Ni
2+
 only at 
concentrations that also block high-VACCs (Lee et al., 1999). Mibefradil was initially 
developed as a selective T channel blocker (Mishra & Hermsmeyer, 1994; Randall & Tsien, 
1997; Todorovic & Lingle, 1998). However, mibefradil also blocks high-VACCs (Fang & 
Osterrieder, 1991; Bezprozvanny & Tsien, 1995; Viana et al., 1997). Later on, mibefradil 
derivative NNC 55-0396 (NNC) emerged as a more selective T-type channel blocker (Huang et 
al., 2004; Li et al., 2005). Unfortunately, a selective T channel blocker with potential scare side 
effects is still an unmet therapeutic goal (Arranz-Tagarro et al., 2014). 
In adrenal medullary chromaffin cells (CCs), the use of selective blockers of high-VACCs has 
revealed their relative density and their contribution to the regulation of Ca
2+
 signalling and the 
exocytotic release of catecholamine (García et al., 2006; Mahapatra et al., 2012). Thus, in 
bovine chromaffin cells (BCCs) the whole cell Ca
2+
 or Ba
2+
 currents (ICa, IBa) are carried 20% by 
L channels, 35% by N channels, and 45% by PQ channels. Furthermore, in adult rat CCs ICa is 
carried 50% by L channels, 30% by N channels, and 20% by PQ channels (Gandía et al., 1995). 
On the other hand, in rat embryo CCs (RECCs) ICa is carried 60% by L channels and 40% by 
non-L channels (N/PQ) (Fernández-Morales et al., 2014). While in BCCs PQ channels dominate 
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the control of exocytosis, in adult rat CCs secretion is mostly controlled by L-channels 
(Fernández-Morales et al., 2009). 
Although RECCs also express T channels, one study concluded that they played no role in 
controlling the depolarisation-evoked exocytosis (Bournaud et al., 2001); in contrast a more 
recent study suggested that the control of hypoxia-induced secretion (HIS response) was exerted 
by T channels (Levitsky & López-Barneo, 2009). However, in another four studies it was 
concluded that the HIS response in RECCs or neonate CCs was mostly controlled by L channels 
(Adams et al., 1996; Thompson et al., 1997; Takeuchi et al., 2001; Fernández-Morales et al., 
2014). 
We planned the present investigation to add some further insight in the question of the 
contribution of T channels to the HIS response of chromaffin cells at early life. We made a 
pharmacological approach to the problem by using NNC, mibefradil, and Ni
2+
 (Carbone et al., 
2014). Because of their known limited selectivity discussed above, we first performed full 
concentration-response curves to define comparatively their IC20, and IC50 to block the whole-
cell inward Ba
2+
 current (IBa) through the high-VACCs of adult BCCs and REECs. Then we 
explored their effects on the K
+
-elicited [Ca
2+
]c transients and secretion in both cell types. 
Finally, we choose the IC20 concentration of the three compounds that caused little inhibition of 
IBa and tested its effects on the HIS response in RECCs. We found that although the three 
compounds fully blocked IBa in a concentration- and time-dependent manner, the threshold 
concentration of the tree compounds partially blocked the HIS response, NNC being the 
compound inducing the maximal blockade. This adds further evidence in support of T channels 
playing a role in the control of such response at early life. How to explain the full blockade of 
the HIS response by L channel blockade and at the same time, its pronounced blockade by T 
channel blockade, and the interaction of L an T channels in the regulation of such response, are 
interesting questions that require new experimental approaches. The use of low concentrations 
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of nifedipine and NNC with cell exposure sufficient to reach drug-receptor equilibrium may 
help to answer those questions. 
2. MATERIAL AND METHODS 
All experimental procedures with animals have been carried out following the guideline 
approved by the Ethical Committee for the care and use of animals of the Medical School, 
Autonomous University of Madrid, Spain, in accordance with the European Community 
Council Directive 2010/63/EEC and with the Spanish Real Decreto RD 53/2013. All efforts 
were made to minimise animal suffering. 
2.1. Culture of bovine and rat embryo adrenal medulla chromaffin cells 
BCCs were isolated from adrenal glands of calves (Bos Taurus), according to standard methods 
with some modifications (Moro et al. 1990). After digestion of the adrenal medulla with 
collagenase, purification of BCCs was achieved by several consecutive centrifugations. Cells 
were suspended in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 5% fetal 
bovine serum, 50 IU/mL penicillin, and 50 µg/mL streptomycin. For preventing the excessive 
growth of fibroblasts, proliferation inhibitors (10 µM cytosine arabinoside, 10 µM 
fluorodeoxyuridine, and 10 µM leucine methyl ester) were added to the medium. 
Rats were housed individually under controlled temperature and lighting conditions with food 
and water provided ad libitum. Chromafﬁn cells were obtained from 18-day-old (E18) rat 
embryos by a protocol previously described for mice (Sorensen et al., 2003) with some 
modiﬁcations. The pregnant Wistar rat was killed by decapitation; the fetuses were rapidly 
extracted and immediately decapitated. Adrenal glands were then rapidly removed from the 
embryos, fat-trimmed, and introduced in 1 ml of an enzymatic solution containing 20 U/ml of 
papain. Adrenals were digested for 20 min; 1 ml of another solution (10% fetal bovine serum, 
2.5 mg/ml albumin from bovine serum and 2.5 mg/ml trypsin inhibitors) to stop the enzymatic 
reaction was then added for 15 s. The cell suspension was centrifuged for 4 min at 104 g, the 
7 
 
supernatant was removed, and the cell pellet was gently resuspended with 0.8 to 1.5 ml of 
DMEM, depending on the final desired cell density. A 100- to 120-µl drop of cell-containing 
solution was plated on poly-D-lysine-coated coverslips of one 12-well plates (for secretion 
experiments) or on 6-well plates (for patch-clamp and [Ca
2+
]c transients experiments). After 1 h 
in an incubator, DMEM (1 ml for 12-well plates and 2 ml for 6-well plates) supplemented with 
4% fetal bovine serum, 50 IU/ml penicillin and 50 µg/ml streptomycin was added to each well. 
Experiments were done in cells that were kept in a water-saturated incubator at 37 °C and a 5% 
CO2 atmosphere for 1 to 2 days. 
2.2. Recording of whole-cell barium currents 
For patch-clamp recording of IBa the perforated-patch mode of the patch-clamp technique was 
used, with amphotericin B as the permeating agent. Tight seals (>5 GΩ) were achieved in a bath 
solution for recording IBa (standard Tyrode solution) composed of the following (in mM): 137 
NaCl, 1 MgCl2, 5 BaCl2, 5.3 KCl, 10 glucose, and 10 HEPES and 0.001 tetrodotoxin, pH 7.3 
adjusted with NaOH. The intracellular solution for the recording of IBa under voltage-clamp 
conditions contained (in mM): 145 glutamic acid, 1 MgCl2, 8 NaCl and 10 HEPES, pH 7.2 with 
CsOH. IBa was recorded at room temperature (22 ± 2 °C) by means of an EPC-10 patch-clamp 
amplifier (HEKA Elektronik, Lambrecht, Germany) controlled by PULSE software running on 
a personal computer. The access resistance was monitored until it decreased to < 20 MΩ. Rs 
averaged 8.6 ± 0.3 MΩ in BCCs and was always compensated by 95%. In all recordings the 
holding potential was –80 mV. IBa was activated in response to 50-ms depolarising 10 mV 
voltage steps from –60 to +60 mV. The test voltage protocol was applied every 15 s. Current 
signals were filtered at 5 kHz, digitised at 50 kHz, and on-line leak subtracted via a P/4 
protocol. 
2.3. Measurements of changes of the cytosolic calcium concentrations 
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To monitor the changes of [Ca
2+
]c, chromaffin cells were incubated for 1 h at 37º C in DMEM 
containing the Ca
2+
 probe Fura-2 AM (10 µM). After this incubation period, the coverslips were 
mounted in a chamber and cells were washed and covered with Tyrode solution composed of 
(mM) 137 NaCl, 1 MgCl2, 5.3 KCl, 2 CaCl2, 10 HEPES, and 10 glucose, pH 7.3 with NaOH. 
The setup for fluorescence recordings was composed of a Leica DMI 4000 B inverted light 
microscope (Leica Microsystems; Barcelona, Spain) equipped with an oil immersion objective 
(Leica 40x Plan Apo; numerical aperture 1.25). The cells were continuously superfused by 
means of a five-way superfusion system at 1 ml/min with a common outlet 0.28 mm-tube driven 
by electrically controlled valves with Tyrode’s solution. Fura-2 was excited alternatively at 340 
± 10 and 387 ± 10 nm using a Küber CODIX xenon 8 lamp (Leica). Emitted fluorescence was 
collected through a 540 ± 20 nm emission filter and measured with an intensified charge 
coupled device camera (Hamamatsu camera controller C10600 orca R2; Japan). Fluorescence 
images were generated at 1-s intervals. Images were digitally stored and analysed using LAS 
AF software (Leica; Barcelona, Spain). A Tyrode external solution of the same composition as 
the one described above was used; drugs were dissolved in this solution.  
2.4. Amperometric recordings of single-vesicle quantal catecholamine release 
Amperometry was chosen to measure catecholamine release at the single cell level. Electrodes 
were built as previously described (Wightman et al. 1991). The amperometer was homemade 
(Universidad Autónoma de Madrid workshop) and was connected to an EPC-10 patch-clamp 
amplifier (HEKA, Lambrecht, Germany) that digitised the signal at 10 kHz sending it to a 
Microsoft personal computer (PC). A 700 mV potential was applied to the electrode with 
respect to an AgCl ground electrode. The electrodes were calibrated according to good 
amperometric practices by perifusing 50 µM noradrenaline dissolved in standard Tyrode’s 
solution and measuring the current elicited; only electrodes that yielded a current between 200 
and 400 pA were used. The coverslips were mounted in a chamber on a Nikon Diaphot inverted 
microscope (Nikon, Tokyo, Japan) used to localize the target cell, which was continuously 
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superfused by means of an eight-way superfusion system with a common outlet driven by 
electrically controlled valves, with a Tyrode solution composed of (in mM): 137 NaCl, 1 
MgCl2, 5.3 KCl, 2 CaCl2, 10 HEPES, and 10 glucose, pH 7.3 with NaOH. The high K
+
 solutions 
were prepared by replacing equiosmolar concentrations of NaCl with KCl. At the time of 
experiment performance, proper amounts of drug stock solutions were freshly dissolved into the 
Tyrode solution and the high-K
+
 solutions.  
2.5. Data analysis and statistics 
The analysis of IBa amplitude was measured at the maximum peak current obtained with a 50-
ms test pulse to 0 mV. Only the cells that held up the entire protocol (control, blocker and wash) 
were included in the statistics. We used a Student´s t test for paired comparisons between 
normalised values between IBa peak before and during blocker treatment. Data are expressed as 
means ± S.E.M. of the number of cells and cultures indicated in parentheses.  
Regarding the changes of [Ca
2+
]c, the data analysis was carried out on a PC; data obtained from 
LAS AF software or Ascent software version 2.4.2, were exported to Excel tables (Microsoft, 
Redmond, WA). Graphs and the mathematical analyses were performed using the Graphpad 
Prism software, version 5.01 (GraphPad Software Inc., San Diego, USA). Peak heights were 
calculated by integrating the [Ca
2+
]c transient over time during the stimulus duration by means 
of  Origin Pro 8 SR2 software, version 8.0891 (OriginLab Corporation, Northampton, USA).  
For amperometric recordings, data analysis was carried out on a PC using Excel (Microsoft, 
Redmond, WA) and IgorPro (Wavemetrics, Lake Oswego OR). Amperometric charge (Qamp) 
was calculated by integrating the amperometric current over time during the stimulus duration 
with a macro written in IgorPro. The number of spikes greater than 7 pA was manually counted 
on an extended graph displayed in the computer screen. A ruler was drawn at 7 pA, and spikes 
going above the threshold amplitude were considered. Differences between means of group data 
fitting a normal distribution were assessed by using either analysis of variance or Kruskal-
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Wallis test for comparison among multiple groups, or Student’s t test for comparison between 
two groups. P < 0.05 was taken as the limit of significance. Only the cells that responded with 
more than 20 spike events during an initial 10-s period of the high K
+
 pulse and that held up the 
entire protocol (control, drug exposure and wash) were included in the statistics. Data are 
represented as mean ± S.E.M. obtained in cells from at least 3 different cultures. *P<0.05; 
**P<0.01 with respect to control, Mann-Whitney’s rank-sum test; P < 0.05 was taken as the 
limit of significance. 
2.6. Chemical products  
Products to make saline solutions, NNC 55-0396 (PubChem CID: 11957578), mibefradil 
(PubChem CID: 16219666), and NiCl2 were purchased from Sigma-Aldrich, Madrid, Spain. 
The following chemicals were used for cell culture: DMEM (Dulbecco’s Modified Eagles 
Medium) and penicillin-streptomycin were from GIBCO, Scotland, UK, fetal bovine serum was 
from PAA laboratories, Pasching, Austria, and papain was from Worthington, Lakewood, NJ. 
The probe Fura-2AM was supplied by Invitrogen, Eugene, Oregon, USA. 
3. RESULTS 
In this investigation three parameters were monitored namely, IBa, [Ca
2+
]c transients, and 
secretion of catecholamine. These three responses are triggered by cell depolarisation that 
causes Ca
2+
 entry through VACCs, an elevation of the [Ca
2+
]c, and the Ca
2+
-dependent release of 
catecholamine (García et al. 2006). The effects of NNC, mibefradil, and Ni
2+
 on these three 
parameters were tested in parallel in BCCs and RECCs. Additionally, we also studied the HIS 
response in RECCs and the effects of threshold concentrations of the three compounds on such 
response. 
3.1. Calcium channel currents 
The whole-cell inward VACCs currents were monitored in cells voltage-clamped at -80 mV 
under the perforated-patch mode of the patch-clamp technique, using 5 mM Ba
2+
 as charge 
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carrier (IBa). Ba
2+
 was used because the current was small when using Ca
2+
 as charge carrier in 
RECCs. Test depolarising pulses of 50 ms duration were sequentially applied at 15-s intervals. 
Under these conditions the effects of NNC could be tested in the same cell in a sandwich-type 
experiment: the initial test pulses generated control currents, then the compound was added and 
finally, it was withdrawn from the superfusion medium to check whether the blocking effect 
was reversible. With NNC the reversibility was slow and partial; thus, a single concentration of 
the compound was tested in every cell. Experiments in BCCs and RECCs were done in parallel. 
The mean IBa amplitude in 137 BCCs was 440± 0.321 pA (± S.EM.); in 122 RECCs IBa 
amplitude was 253 ± 12 pA. These values are consistent with a higher surface of BCCs (9.87± 
0.31 pF; n=115 cells) with respect RECCs (6.27± 0.17 pF; n=82 cells). 
Fig. 1 summarises the pattern of IBa blockade elicited by single or increasing concentrations of 
NNC. Panel A shows a family of IBa traces generated by depolarising test pulses given at 10 mV 
steps from -60 to +60 mV, applied on an example BCC (A,a). As expected from the use of Ba
2+
 
as charge carrier, IBa did not inactivate. In the presence of 5 μM NNC, the current traces were 
blocked by 70% (A,b). After 5 min of NNC washout, the currents recovered only partially 
(A,c). I-V curves before (control), during NNC perifused at 1 μM (NNC), and after NNC 
washout are graphed in panel B. Threshold current was at -30 mV, peak current at 0 mV, and 
the reversal potential at +60 mV. At 1 μM, NNC blocked IBa by 40% but there was no shift of 
the I-V curve; at this low concentration, the peak current recovered its control value after 5 min 
of NNC removal. Panel C shows a concentration-response curve for the blocking effects of 
NNC on IBa. The threshold concentration was at 30 nM, the IC50 was 1.86 μM, and full blockade 
was achieved at 10 μM. 
Fig. 1D,E,F summarises the results obtained with NNC in REECs. The family of control IBa 
currents (Da) are reduced by 70% in the presence of 5 μM NNC (Db), with an incomplete 
recovery after 5 min of compound washout (Dc). In the I-V curves of panel E, the threshold IBa 
was at -50 mV, the peak current at -10 mV, and the reversal potential at -60 mV; in the presence 
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of 1 μM NNC, IBa peak was reduced by 35% with full recovery upon compound washout. The 
concentration-response curve of panel F shows a threshold concentration at around 50 nM, an 
IC50 of 2.09 μM, and 75% of current blockade at 10 μM. The blockade elicited by mibefradil 
exhibited characteristics similar to those of NNC. Of interest was the fact that at 5 μM 
mibefradil shifted to the left the I-V curve for IBa by 10 mV (not shown) in RECCs but not in 
BCCs. Fig. 2A shows that in BCCs the threshold blockade is between 30 and 100 nM, the IC50 
is at 4.95 μM, and full current blockade was achieved at 30 μM. Similar outcomes were found 
in RECCs, with an IC50 of 4.45 μM. In BCCs Ni
2+
 exerted a concentration-dependent blockade 
of IBa, with threshold concentrations at around 5 μM, IC50 of 70 μM and full blockade at 1 mM 
(Fig. 2C). In RECCs a somehow lower IC50 was obtained namely, 41 μM; threshold and full 
blockade concentrations were similar to those of BCCs, around 5 μM and 1 mM (Fig. 2D).  
3.2. Time course of the induction of IBa blockade and of its reversibility  
To study the time course of the induction of IBa blockade elicited by NNC, and the degree of 
recovery of the initial current amplitude upon withdrawal of the compound from the perifusing 
external solution, CCs were voltage-clamped at -80 mV and continuously challenged with test 
depolarising pulses to 0 mV applied with a cadence of 15 s. Because NNC caused full blockade 
of IBa at 50 μM (Fig. 1C) it was expected that this high concentration of the compound would 
cause full blockade of the current in few seconds. This was not the case, as illustrated in the 
example BCC of Fig. 3A. During the first minute of cell exposure to NNC, a tiny blockade of 
IBa was initiated. Such blockade developed faster after 1 min but took near 2 additional minutes 
to reach the full current blockade. After 3 min exposure to NNC, its removal gave rise to the 
initiation of an extremely slow recovery phase; in fact after 5 min, the IBa amplitude was only 
12% of the initial (Fig. 3A). In the RECC shown in Fig. 3B, the outcome was similar to the 
BCC namely, an initial phase of slow and gradual blockade that lasted 2 min and then a faster 
phase that reached full blockade in 2 min. Again, the rate of IBa recovery after NNC washout 
was less than 10% in 5 min. 
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The initial phase of slow blockade induced by NNC was absent in the BCC displayed in Fig. 3C 
and exposed to 50 μM mibefradil. The blockade was initiated from the very beginning of cell 
exposure to the compound and took about 2.5 min to reach full current blockade. As for NNC, 
the washout of mibefradil after exposure to this high concentration was very slow; after 6 min 
of washout only about 15% of the initial IBa was recovered. The blockade and recovery were 
clearly concentration-dependent. For instance, the RECC of Fig. 3D was perifused with 10 μM 
mibefradil that gave rise to a gradual blockade that did not reach equilibrium because the 
compound was removed after only 2 min of cell exposure. At this lower concentration, the rate 
of current recovery was faster although curiously, it reached a plateau after a minute or so at 
about 50% of the fraction of current initially blocked. For the sake of comparison, the time 
course of the blockade instauration and the exit from blockade, was studied with inorganic 
nickel. At 50 μM, Ni2+ produced a fast decrease of IBa in about 15 s in both the BCC (40% 
blockade, Fig. 3E) and the ECC explored (60% blockade, Fig. 3F). The recovery was also 
rapidly (15 s) and fully established after the removal of Ni
2+
 from the external solution. 
3.3. Elevations of the cytosolic Ca2+ concentrations triggered by K+ depolarisation 
Blockade of VACCs by NNC should be paralleled by a similar blockade of the K
+
-induced 
[Ca
2+
]c transients. This happened to be the case as exemplified in the fura-2-loaded BCC and 
RECC that responded to successive K
+
 pulses (45 mM K
+
, 5 s) given at 3 min intervals, with 
initial transient elevations of [Ca
2+
]c (Fig. 4A, C). At 10 μM, NNC drastically reduced the 
[Ca
2+
]c transient amplitude in a clear time-dependent manner in the BCC of Fig. 4A. Upon NNC 
withdrawal, a partial time-dependent recovery was produced. The blockade exerted by NNC on 
the RECC was more gradual and scarcely reverted upon NNC washout (Fig. 4C). The 
concentration-response curves clearly indicated the time-dependence of the induction of the 
blockade elicited by NNC in both BCCs (Fig. 4B) and RECCs (Fig. 4D). It was somehow 
puzzling that in RECCs NNC could not fully block the [Ca
2+
]c transients, even after 7 min 
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exposure to the higher concentrations used (Fig. 4D). In BCCs, however, about 90% blockade 
was achieved after 7 min exposure to NNC (Fig. 4B). 
The effects of mibefradil on BCCs were superimposable to those of NNC; the compound effects 
exhibited a time-dependence with 40% blockade after 1 min exposure and over 80% blockade at 
the 7th minute (Fig. 5A). The blockade was also time dependent in RECCs, 40% after 1 min 
and 75% after 7 min (Fig. 5B). It was somehow surprising that the blocking effects of Ni
2+
 also 
exhibited some time dependence in BCCs, particularly at the concentrations of 10-30 μM (Fig. 
5C). In RECCs the time dependence of the blockade was less pronounced but the maximum 
blockade achieved was about 50-60% (Fig. 5D). 
3.4. Quantal catecholamine release responses triggered by high K+ 
To study the effects of NNC, mibefradil, and Ni
2+
 on the quantal release of catecholamine, 
single BCCs or RECCs were stimulated 3-4 times with pulses of a high K
+
 solution (75 mM K
+
, 
30 s). The spike amperometric responses of example BCC and RECC are shown in Fig. 6A, B. 
An initial spike burst was usually followed by more infrequent spikes along the K
+
 stimulation 
period. This protocol produces quite reproducible responses within the same cell (not shown). 
At 5 μM, NNC elicited near full blockade of the response in the BCC and the RECC; partial 
time-dependent recovery was observed in both cell types after NNC washout (Fig. 6A, B). 
Pooled data showed that in BCCs, 5 μM NNC blocked by over 80% the spike number and total 
secretion (Qamp), with partial recovery at 5-10 min after washout (Fig. 6C). Mibefradil at 5 μM 
also caused 90% blockade with time-dependent full recovery of the response after washout (Fig. 
6D). At 50 μM, Ni2+ caused near full blockade of secretion with partial recovery at 5 min after 
washout (Fig. 6E). The blockade elicited by NNC and mibefradil in RECCs was around 80% 
(Fig. 6F, G) but 50 μM Ni2+ caused only around 65% blockade (Fig. 6H). 
3.5. Effects of threshold concentrations of NNC, mibefradil, and Ni2+ on the hypoxia-induced 
secretion in rat embryo chromaffin cells. 
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We have defined the threshold concentrations of NNC, mibefradil, and Ni
2+
 as those 
concentrations that achieve 20% blockade of the high-VACCs current (Fig. 1 and 2) namely, 0.4 
μM NNC, 0.9 μM mibefradil, and 25 μM Ni2+. The HIS response seems to be mediated by high-
VACCs as well as low-VACCs (see Discussion). Because of the apparent selectivity of these 
three compounds on T-type currents (see Introduction) it was reasonable to test whether the 
threshold concentrations to block the high-VACCs could elicit a blockade of the HIS response 
more pronounced than that expected from only 20% blockade of IBa. 
Cells were exposed 3 times to a 1 min hypoxia (less than 5% O2), that produced secretory spike 
events along the time period of hypoxia; those responses were quite similar at hypoxia pulses P1 
and P2 (Fig. 7A, B) and decreased by 16±8% for Qamp and 17 ± 8% for spike number during 
P3 (Fig. 7B; n=18 control cells). Given 5 min before and during the hypoxia exposure, 0.4 μM 
NNC caused as much as 73 ± 5% blockade of Qamp and 76 ± 1.7 blockade of spike number; 
recovery was complete after 5 min washout (Fig. 7C). At 0.9 μM, mibefradil inhibited the HIS 
response by 35 ± 6.7% (Qamp) and 37 ± 6.2% (spike number); recovery after 5 min washout 
was near 80% (Fig. 7D). Finally, 25 μM Ni2+caused around 50% blockade of the HIS response 
with full recovery after washout (Fig. 7E). 
4. DISCUSSION 
In line with the general belief that reputed blockers of the T-subtype of low-VACCs also target 
the high-VACCs (García et al., 2006; Catterall, 2012; Mahapatra et al., 2012; Carbone et al., 
2014), we have found here that NNC, mibefradil and Ni
2+
 caused a full concentration-dependent 
blockade of CC IBa and hence, of the three subtypes of high-VACCs expressed by BCCs and 
RECCs namely, L, N, and PQ. Of interest was the observation that the three compounds 
exhibited similar potencies to block IBa in RECCs and BCCs (see their IC20 and IC50 in table 1). 
A natural consequence of IBa inhibition was the mitigation of the K
+
-elicited [Ca
2+
]c transients 
that are initially shaped by the Ca
2+
 entering through the VACCs, opened by membrane 
depolarisation (Douglas & Poisner, 1961). However, the incomplete blockade of the K
+
-elicited 
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[Ca
2+
]c transients exerted by NNC, mibefradil, and Ni
2+
 contrasts with the full blockade of IBa . 
These differences could be explained on the basis of the different protocols used to monitor IBa 
(50 ms depolarising pulses) and the [Ca
2+
]c changes (5 s of K
+
 depolarisation). While in the first 
case the Ca
2+
 entering the cell through VACCs is the only variable implicated, in the second 
case the [Ca
2+
]c transient is shaped by Ca
2+
 entry but also by its redistribution and clearance by 
the endoplasmic reticulum (Alonso et al., 1999) and mitochondria (Montero et al., 2000). 
Furthermore, the inactivation of VACCs does not occur when measuring IBa (Hernández-Guijo 
et al., 2001), but it is important with K
+
 depolarisation produced during several seconds 
(Villarroya et al., 1999). 
An additional feature of the blockade of IBa and the [Ca
2+
]c transients was its time dependence; 
in the case of Ni
2+
 the blockade developed in few seconds, but lasted a few minutes to reach 
equilibrium in the case of NNC and mibefradil. Also the recovery from blockade of the two 
parameters was slow for NNC and mibefradil; in fact, in the case of NNC the recovery was 
meager after 10 min washout. This behaviour reminds the slow time course of IBa blockade and 
its slow recovery in BCCs exerted by lipophilic compounds such as R56865 (Garcez-do-Carmo 
et al., 1993), dotarizine and flunarizine (Villarroya et al., 1995), lubeluzole (Hernández-Guijo et 
al., 1997), and ITH33/IQM9.21 (Maroto et al., 2011). The slow IBa blockade of mibefradil 
reminds that of dotarizine and the extremely slow blockade exerted by NNC reminds that of 
R56865 and lubeluzole. An additional feature of some of these blockers as for instance 
lubeluzole (Hernández-Guijo et al., 1997) or R56865 (Garcez-do-Carmo et al., 1993) is their 
ability to cause the inactivation of VACCs currents, a property that is not shared by NNC and 
mibefradil in the present experiments, neither by dotarizine in previous experiments (Villarroya 
et al., 1995). This gradual blockade could be linked to a time dependent progressive 
accumulation of NNC and mibefradil at the plasmalemma of CCs, as the case is for R56865, 
dotarizine, and lubeluzole, as well as for another array of so-called wide-spectrum blockers of 
VACCs having a high octanol/water partition coefficient (Lara et al., 1997). In this context, the 
slow development of VACCs blockade exerted by mibefradil and particularly NNC, should be 
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considered when using them as pharmacological probes to block a particular [Ca
2+
]c signal and 
its associated physiological or physiopathological function. In fact, their potencies to block such 
function could be considerably higher if the experimental design included a period of several 
minutes to allow the equilibration of mibefradil and NNC with the lipid environment of their 
target channel. 
The secretory response triggered by pulses of 75 mM K
+
 was nearly fully blocked by 5 μM each 
of NNC and mibefradil and by 50 μM Ni2+. At 75 mM, K+ drives the membrane potential of 
CCs from -60 to 0 mV (Orozco et al., 2006); at this highly depolarised membrane potential the 
L, N, and PQ high-VACCs are opened and therefore, their blockade by the high concentrations 
of NNC, mibefradil, and Ni
2+
 could explain the pronounced blockade of such response. 
To explore the effects of NNC, mibefradil, and Ni
2+
 on the HIS response of RECCs, we first 
considered their ability to block IBa and hence, the high-VACCs, at threshold concentrations 
(IC20) and at intermediate concentrations (IC50) (table 1). The blockade of the HIS response 
exerted by 25 (2 x IC20 to block IBa) and 41 μM Ni
2+
 (IC50 to black IBa) was 44% and 60%. In the 
case of mibefradil the blockade exerted by 0.9 μM (IC20 to block IBa) was 35% and that evoked 
by 4.4 μM (IC50 to block IBa) was 71%. However, in the case of NNC, at 0.4 μM (the IC20 to 
block IBa) the blockade of the HIS response was already near maximum (73%). This indicates 
that the blockade elicited by mibefradil and Ni
2+
 at their IC50 concentrations likely involved the 
blockade of high-VACCs, while the blockade exerted by 0.4 μM NNC (its IC20) likely involved 
VACCs other than the L, N, and PQ, most probably the T-type channels. This is consistent with 
the initial study of the effects of NNC on the various subtypes of VACCs expressed in HEK293 
cells; in this heterologous system NNC blocked T channel currents with an IC20 of 6.8 μM, but 
the high-VACCs currents were not affected even at concentrations of 100 μM (Huang et al., 
2004). The native high-VACCs of CCs seem to be more susceptible to blockade by NNC, with 
IC50 of 1.8 μM for BCCs and 2.1 μM for RECCs. In spite of this, the judicious use of threshold 
concentrations of NNC to block the high-VACCs, namely at submicromolar concentrations, 
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could be highly useful to further explore the contribution of T channels to the HIS response at 
early life, as well as other function of CCs at embryonic or neonatal life; Ni
2+
 and mibefradil 
seems to have more limitations to distinguish between high- and low-VACCs mediated 
functional responses of CCs. 
Three conclusions emanate from this study: (1) NNC, mibefradil, and Ni
2+
 cause a full 
concentration-dependent blockade of high-VACCs of BCCs and RECCs; (2) the low-VACCs of 
the T-subtype expressed by CCs at early life may be efficiently blocked by threshold 
concentrations of NNC that do not ostensibly block the high-VACCs of RECCs; and (3) the 
experiments with NNC add evidence in support of the previous suggestion that T channels are 
controlling the HIS response in neonatal rat adrenal slices (Levitsky & López-Barneo, 2009). 
However, early (Thompson et al., 1997; Takeuchi et al., 2001; Adams et al., 1996) and more 
recent observations (Fernández-Morales et al., 2014) suggest that L channels also contribute to 
the regulation of the HIS response at early life. How L and T channels interact in the regulation 
of such response is an interesting question that requires new experimental approaches to be 
answered. The judicious use of low concentrations of nifedipine and NNC and the cell exposure 
to sufficient time to allow drug-receptor equilibrium, should gain in selectivity to target L and T 
channels, respectively, and thus contribute to clarify their role in the regulation of the HIS 
response. 
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Figure captions 
Fig. 1. Concentration-dependent blockade of the whole-cell Ba
2+
 current (IBa), elicited by NNC 
55-0396 (NNC) in bovine chromaffin cells (BCCs, panels A, B, C) and rat embryo chromaffin 
cells (RECCs, panels D, E, F). IBa was recorded under the perforated-patch mode of the patch-
clamp technique, using 5 mM Ba
2+
 as charge carrier, at a holding potential of -80 mV. Test 
pulses to various voltages had a duration of 50 ms and were given at 15 s intervals in 10 mV 
steps. A family of IBa traces from an example BCC was obtained upon the application of I-V 
protocols before (control), after 5 min of perifusion with NNC, and 5 min after its washout. 
Similar IBa trace families are shown in Da,b,c for an example RECC. B and E are pooled results 
of I-V curves for BCCs and RECCs respectively; note here the full IBa recovery with 1 μM 
NNC, compared with the partial recovery in A and B where 5 μM NNC was used. 
Concentration-response curves for the blockade of peak IBa elicited by NNC are graphed in 
panels C (BCCs) and F (RECCs); these data are means ± S.E.M. of the number of cells shown 
in parentheses from at least 3 different cultures. *P<0.05 with respect to control (Mann-
Whitney´s rank-sum test). 
Fig. 2. Concentration-dependent blockade of the whole-cell peak Ba
2+
 current (IBa) elicited by 
mibefradil and Ni
2+
 in bovine chromaffin cells (BCCs, panels A, C) and rat embryo chromaffin 
cells (RECCs, panels B, D). Experimental protocols are as those described in Fig. 1; peak 
current was elicited with test depolarising pulses to -10 or 0 mV to obtain peak current. The 
compounds were present 5 min before and during the test pulses. Peak currents are normalised 
as % of control currents in the absence of compound; a single concentration of the compounds 
were tested in separate cells. Data are means ± S.E.M. of the number of cells shown in 
parentheses from at least 3 different cultures. The IC50 for each compound was calculated from 
each graph.  
Fig. 3. Time course of the blockade of the whole-cell Ba
2+
 current (IBa) elicited by NNC 55-
0396 (NNC), mibefradil, and Ni
2+
 in bovine chromaffin cells (BCCs, panels A, C, E) and rat 
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embryo chromaffin cells (RECCs, panels B, D, F). Experimental protocol was as in Fig. 1. The 
compounds were applied during 3 min and the concentrations indicated by the horizontal bars in 
each panel. Peak current amplitudes are given in the ordinates in pA; the abscissae show the 
time in minutes since the braking down into the cell cytosol with the perforated-patch. Note that 
generally, IBa amplitudes are smaller in RECCs with respect BCCs. Data are from example cells. 
Fig. 4. Concentration-dependent blockade of the K
+
-evoked elevation of the cytosolic Ca
2+
 
concentration, elicited by NNC 55-0396 (NNC) in bovine chromaffin cells (BCCs) and rat 
embryo chromaffin cells (RECCs). Cells preloaded with the Ca
2+
 probe fura-2 were challenged 
with a high K
+
 solution (45 mM K
+
 with isoosmotic reduction of NaCl and containing 2 mM 
Ca
2+
) applied for 5 s at 3 min intervals (dots at the bottom of the Ca
2+
 transient traces in panels 
A and B). Cells were challenged with the K
+
 solution before and during the application of 10 
μM NNC (3 K+ pulses, as shown by the horizontal bars on top of panels A and B, for the 
example BCC and RECC, respectively). Upon NNC removal, 2-3 additional K
+
 pulses were 
applied to explore response recovery. To explore the concentration-dependent blockade of the 
[Ca
2+
]c transients, a single NNC concentration per cell was tested. The concentration-dependent 
curves displayed in panels B (BCCs) and D (RECCs) were calculated after 1, 4, or 7 min of cell 
exposure to NNC. Data are normalised as % of the pre-NNC [Ca
2+
]c transient amplitude at each 
of the time period of cell exposure to NNC, within each individual cell. Data in panels B and D 
are means ± S.E.M. of the number of cells shown in parentheses, from at least 3 different 
cultures. 
Fig. 5. Concentration-response curves on the blockade of the K
+
-elicited [Ca
2+
]c transients, 
exerted by mibefradil (panel A, B) and Ni
2+
 (panels C, D) in bovine chromaffin cells (BCCs, 
panels A, C) and rat embryo chromaffin cells (RECCs, panels B, D). The experimental 
protocols and the plotting of the curves were performed as described in Fig. 4. Data are means ± 
S.E.M. of the number of cells shown in parentheses from at least 3 different cultures. 
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Fig. 6. Blockade by NNC 55-0396 (NNC), mibefrail, and Ni
2+
 of the quantal catecholamine 
release responses in bovine chromaffin cells (BCCs) and rat embryo chromaffin cells (RECCs) 
stimulated with high K
+
. Three-four depolarising pulses of 30 s duration, given with a solution 
containing 75 mM K
+
-low Na
+
 and 2 mM Ca
2+
, were sequentially applied to the example cells 
of panels A, B, and C (bottom horizontal bars below each trace, P1, P2, P3, P4). P1 was applied 
before exposure to the blocker, P2 after 30 s exposure (Ni
2+
) or 5 min exposure (mibefradil, 
NNC), and P3-P4 after 5-10 min of compound washout. A, example trace of 4 amperometric 
spike traces produced in response to four K
+
 pulses (P1, P2, P3, P4) in an example BCC; P2 was 
applied in the presence of NNC. B, protocol as in A but the experiment was performed in an 
example RECC. C to H, pooled results on the extent of the blockade of the K
+
 evoked secretory 
response, elicited by NNC (C, F), mibefradil (D, G), and Ni
2+
 (E, H) in BCCs (C, D, E) or 
RECCs (F, G, H). Data are normalised as % of P1 within each cell, both as the number of 
secretory amperometric spikes per stimulus (right ordinates) or as the total cumulative secretion 
per stimulus (summatory of spike areas, left ordinates). ***P<0.001, ###P<0.001 with respect 
to P1 (Mann-Whitney´s rank-sum test). 
Fig. 7. Blockade of the hypoxia-induced secretion (the HIS response) elicited by NNC 55-0396 
(NNC), mibefradil, and Ni
2+
 in rat embryo chromaffin cells (RECCs). Cells were exposed 3 
times to a hypoxic solution (below 5% O2) for 1 min at 5 min intervals. The quantal release of 
catecholamine was amperometrically monitored with a carbon fibre mocroelectrode at the 
single-cell level. A, example secretory spike traces of the HIS responses obtained in a control 
RECC challenged three successive times with the hypoxic solution (P1, P2, P3). B, pooled 
normalised data in each cell, of total secretion per hypoxic stimulus in PC (left ordinate) or in 
the number of spikes per hypoxic stimulus (right ordinate). C, D, E are the normalised data 
obtained from experiments similar to those of panel A, but exposing the cells 5 min before and 
during P2 to threshold concentrations of NNC or mibefradil 5 min before and during P2; Ni
2+
 
was present 30 s before and during P2. Data in panels B to E are means ± S.E.M. *P<0.05, 
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#P<0.05, **P<0.01, ***P<0.001, ###P<0.001 with respect to P1 (Mann- Whitney´s rank-sum 
test). 
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Table 1. Relative blockade by Ni
2+
, mibefradil, and NNC, of the HIS response of RECCs, 
exerted by a low concentration (close to the threshold concentration required to block IBa by 
20%) and at an intermediate concentration (IC50 to block IBa). Data are means ± S.E.M. of the 
number of cells shown in n, from the number of different cell cultures indicated by N. 
a
 P < 0.05, comparing mibefradil with NNC; ANOVA-one way, with Tukey post-hoc test. 
 
Compound Concentration (μM) Qamp n/N 
Ni
2+
 
25 (2 x IC20 IBa ) 
41 (IC50 IBa ) 
44±9.5 
60±4.9 
12/3 
8/3 
Mibefradil 
0.9 (IC20 IBa ) 
4.4 (IC50 IBa) 
35±6.7 
71±4.3 
10/3 
7/2 
NNC  0.4 (IC20 IBa ) 73±5
a
 13/3 
Table
ANSWERS TO EDITOR COMMENTS Ref.: Ms. No. EJP-40809 
“(…) following action is required: 
- Use S.E.M. (not SE). 
- To indicate statistical significance use the uppercase P instead of p.” 
 
Style changes request were done as yours suggestions. 
  
ANSWERS TO REVIEWER COMMENTS Ref.: Ms. No. EJP-40809 
REVIEWER #1 
Authors of this manuscript, José C. Fernández-Morales, J. Fernando Padín, Stefan Vestring, 
Diego C. Musial, Antonio-Miguel G. de Diego and Antonio G. García, we would like to thank 
your kind positive comments to our work. 
REVIEWER #2 
“The study is seeking to understand the possibility of selective blockage of T-type low-
voltage activated calcium channels (VACCs) in the selected cell types elucidated for 
embryo and neonatal life, by using several pharmacological agents for high-voltage 
activated calcium channels. The study's approach is a step-wise approach with patch 
clamp technique for measurement of several related ion channels. The results are good in 
quality and clearly presented. The conclusion drawn from the study is reasonable and 
understandable. Overall, it is a good study.” 
We thanks your positive comments to our study. 
“Several questions for the study are as followings: 
1) It seems all the study condition (patch clamp study) for the ion channels are at 
room temperature at 22 °C, would it come out with a different results if running at 
37 °C?” 
You are right. The path-clamp study of calcium channels currents has been performed at 22 ºC, 
as the myriad studies done in different laboratories. Your point on the replication of these 
experiments at the physiological temperature of 37 ºC is well taken. You should consider, 
however, that the gating and conductance of calcium channels is scarcely dependent on 
temperature. Additionally, we were using Ba
2+
, instead of Ca
2+
, as charge carrier. Unlike Ca
2+
, 
Ba
2+
 does not elicit the inactivation of calcium and thus the fractional blockade by Ni
2+
, 
mibefradil, and NNC 55-0396 of the whole-cell IBa should be similar at 22 ºC and 37 ºC. 
2) “Regarding the calcium channels in this study, does the mitochondrial calcium 
play any role into the regulations?” 
For the last 14 years, our laboratory has thoroughly investigated the contribution of Ca
2+
 
buffering by mitochondria in the regulation of calcium channels, cytosolic Ca
2+
 transients, and 
the exocytotic release of catecholamine in chromaffin cells (see for instance our recent review 
García et al., Cell Calcium. 2012;51:309-20). In fact, in voltage-clamped bovine chromaffin 
cells, we found that the interruption with protonophores of mitochondrial Ca
2+
 buffering, caused 
the inactivation of calcium channels (Hernandez-Guijo et al., J Neurosci. 2001;21:2553-60). 
Recently, we found similar results in rat embryo chromaffin cells recording whole-cell channel 
*Response to Reviewers
currents using Ca
2+
 as charge carrier. At present, we have this work under revision in Pflüger’s 
Archiv; we can of course send you the graphs and/or the entire Ms. if you wish to see it. 
3) “Is hypoxia-induced secretion of catecholamine a biomarker for blockage of 
VACCs?” 
We have recently published a study showing that hypoxia elicited secretion from rat embryo 
chromaffin cells is mostly controlled by the L-subtype of voltage-activated calcium channels; 
the N- and PQ-subtypes channels contributed to a much lesser extent (Fernández-Morales et al., 
Am J Physiol Cell Physiol. 2014;307:C455-65). 
4) “In figure 7, the data is only showed for measurement of catecholamine release by 
low doses of the pharmacological agents, is there data show at high doses of these 
agents?” 
These experiments were planned to figure out if threshold concentrations of Ni
2+
, mibefradil, 
and NNC 55-0396 that blocked very little the high-voltage activated calcium channels, 
substantially inhibited the low-voltage activated T-type channels. This was achieved only with 
threshold concentrations of NNC 55-0396. At higher concentrations, the HIS response will 
indeed be blocked by the three agents, as the case was for barium currents and K
+
-elicited 
[Ca
2+
]c transients. 
We thank your comments that will inspire future experiments in chromaffin cells at early life.  
 
